Epstein-Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseasesOcrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosisDifferential Runx3, Eomes, and T-bet expression subdivides MS-associated CD4+ T cells with brain-homing capacity
author
type
label
Jasper Rip